Week's top
Latest news
Unread news
Subscribe

Science X Account

Remember me

Sign in with

Forget Password?

Not a member? Sign up

Addiction
Alzheimer's disease & dementia
Arthritis & Rheumatism
Attention deficit disorders
Autism spectrum disorders
Biomedical technology
Cardiology
Dentistry
Diabetes
Diseases, Conditions, Syndromes
Endocrinology & Metabolism
Gastroenterology

Genetics
Gerontology & Geriatrics
Health
Health informatics
HIV & AIDS
Immunology
Inflammatory disorders
Medical economics
Medical research
Medications
Neuroscience
Obstetrics & gynaecology

Oncology & Cancer
Ophthalmology
Other
Overweight & Obesity
Parkinson's & Movement disorders
Pediatrics
Psychology & Psychiatry
Radiology & Imaging
Sleep disorders
Sports medicine & Kinesiology
Surgery
Vaccination

Asthma
Breast cancer
Cardiovascular disease
Chronic obstructive pulmonary disease
Colon cancer
Coronary artery disease

Dementia
Depression
Heart attack
Heart disease
High blood pressure
Influenza

Kidney disease
Leukemia
Lung cancer
Malaria
Melanoma
Multiple sclerosis

Myocardial infarction
Ovarian cancer
Post traumatic stress disorder
Rheumatoid arthritis
Schizophrenia
Skin cancer

Stroke
Type 2 diabetes
Full List »

Home
Archive
01/04/2022

Archive: 01/04/2022

Universal HepB vaccination recommended for adults age 19 to 59

Hepatitis B (HepB) vaccination should be administered to adults aged 19 to 59 years and to those aged 60 years or older with risk factors for HepB, according to updated recommendations published in the April 1 issue of the ...

Apr 1, 2022

0

6

160,000 lbs of SKIPPY peanut butter recalled due to metal fragments

Check your cupboards for any SKIPPY peanut butter, since you may need to throw the jar out.

Apr 1, 2022

0

3

3D facial analysis shows biologic basis for gender-affirming surgery

Gender-affirming facial surgery (GFS) is pursued by transgender individuals who desire facial features that better reflect their gender identity. Until now, there have been few objective guidelines to justify and facilitate ...

Apr 1, 2022

0

16

COVID-19 vaccine-associated menstrual symptoms reported in non-menstruating people

Many people who do not usually menstruate reported experiencing breakthrough bleeding or other period symptoms after receiving a COVID-19 vaccine, according to new findings from an online survey by researchers at Washington ...

Apr 1, 2022

0

3

Are COVID-19-linked arrhythmias caused by viral damage to the heart's pacemaker cells?

The SARS-CoV-2 virus can infect specialized pacemaker cells that maintain the heart's rhythmic beat, setting off a self-destruction process within the cells, according to a preclinical study co-led by researchers at Weill ...

Apr 1, 2022

0

41

Can weekly prednisone treat obesity?

Obese mice that were fed a high-fat diet and that received prednisone one time per week had improved exercise endurance, got stronger, increased their lean body mass and lost weight, reports a new Northwestern Medicine study. ...

Apr 1, 2022

0

66

Medicaid health plan community health workers have positive impact on care

Community health workers employed by Medicaid health plans can help low-income people who face barriers to care rely less on the emergency room, and more on outpatient care, a new study finds. The CHWs in the study worked ...

Apr 1, 2022

0

22

Immune system 'sentinel' cells key to maintaining and regulating response to immunotherapy

The presence of dendritic cells, so-called 'sentinel' immune cells, is vital to maintain and regulate the balance of the body's immune response. Researchers have discovered an essential role of these cells in the treatment ...

Apr 1, 2022

0

48

Millions of people could lose health insurance coverage when the COVID-19 emergency ends

Adam Sparks earns $13 an hour as an assistant manager at a movie theater in a suburb of Des Moines, Iowa. It's enough for the 24-year-old to pay for most necessities—except health care.

Apr 1, 2022

0

17

COVID antiviral drug molnupiravir eliminates actively infectious SARS-CoV-2 virus by day 3 of therapy

New data to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022, Lisbon, 23-26 April) shows that participants taking the new anti-COVID drug molnupiravir eliminate actively ...

Apr 1, 2022

0

51

page 3 from 8

«
»

Phys.org — Phys.org

Daily science news on research developments and the latest scientific innovations

Tech Xplore

The latest engineering, electronics and technology advances

ScienceX — Science X

The most comprehensive sci-tech news coverage on the web

Newsletters

Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech news updates in your email inbox

Follow us

Top
Home
Search
Mobile version

Help
FAQ
About
Contact

Science X Account
Premium Account
Newsletter
Archive

Android app
iOS app
RSS feeds
Push notification

© Medical Xpress 2011 - 2025 powered by Science X Network

Privacy policy Terms of use Medical Disclaimer

E-mail newsletter

Follow us